March 22, 2023
MarketScreener
Talc Plaintiffs Will Press to Reopen Courthouse Doors
(marketscreener.com) In denying Motion for Rehearing, Third Circuit affirms J&J's 'Texas Two-Step' ba... See more »
C. R. Bard posted a video "Caterpillar Arterial Embolization Devices" on YOUTUBE
See Video »
March 23, 2023
MarketScreener
AstraZeneca's Calquence receives first approval in China
(marketscreener.com) AstraZeneca PLC on Thursday said its drug Calquence received its first approval ... See more »
March 23, 2023
MarketScreener
BAYER AG : Berenberg keeps its Buy rating
(marketscreener.com) In his latest research note, analyst Sebastian Bray confirms his positive recomm... See more »
March 23, 2023PMLiVE
AbbVie's Parkinson's disease therapy application rejected by FDA
The regulator has requested more information on the pump used to administer ABBV-95... See more »
March 21, 2023StreetInsider
Olympus Webinar Highlights Differences in Single-Use and Reusable Bronchoscope Performance
CENTER VALLEY, Pa., March 21, 2023 /PRNewswire/ -- Olympus today announced it is hosting a webinar le... See more »
March 22, 2023MarketScreener
Cosmo Pharmaceuticals announces that Cosmo Intelligent Medical Devices - IMD Ltd, fully owned subsidiary of Cosmo Pharmaceuticals, and Medtronic to expand cooperation on GI Genius
(marketscreener.com) Cosmo Pharmaceuticals N.V. / Key word: Agreement Cosmo Pharmaceuticals announces... See more »
March 23, 2023MarketScreener
AstraZeneca : 2022 Sustainability Highlights presentation
(marketscreener.com) 2022 Sustainability Highlights Conference call for investors and analysts 22 Mar... See more »
March 23, 2023FinanzNachrichten
AbbVie: Phase 3 Induction Study With Risankizumab Meets Endpoints
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - AbbVie (ABBV) reported positive top-line results from INSPIRE, a... See more »
March 21, 2023Seeking Alpha
Bayer, Orion's Nubeqa gets approval in China for expanded use in prostate cancer
March 22, 2023
MarketScreener
Talc Plaintiffs Will Press to Reopen Courthouse Doors
(marketscreener.com) In denying Motion for Rehearing, Third Circuit affirms J&J's 'Texas Two-Step' ba... See more »
March 23, 2023
MarketScreener
AstraZeneca's Calquence receives first approval in China
(marketscreener.com) AstraZeneca PLC on Thursday said its drug Calquence received its first approval ... See more »
March 23, 2023
MarketScreener
BAYER AG : Berenberg keeps its Buy rating
(marketscreener.com) In his latest research note, analyst Sebastian Bray confirms his positive recomm... See more »
March 23, 2023PMLiVE
AbbVie's Parkinson's disease therapy application rejected by FDA
The regulator has requested more information on the pump used to administer ABBV-95... See more »
March 21, 2023StreetInsider
Olympus Webinar Highlights Differences in Single-Use and Reusable Bronchoscope Performance
CENTER VALLEY, Pa., March 21, 2023 /PRNewswire/ -- Olympus today announced it is hosting a webinar le... See more »
March 22, 2023MarketScreener
Cosmo Pharmaceuticals announces that Cosmo Intelligent Medical Devices - IMD Ltd, fully owned subsidiary of Cosmo Pharmaceuticals, and Medtronic to expand cooperation on GI Genius
(marketscreener.com) Cosmo Pharmaceuticals N.V. / Key word: Agreement Cosmo Pharmaceuticals announces... See more »
March 23, 2023MarketScreener
AstraZeneca : 2022 Sustainability Highlights presentation
(marketscreener.com) 2022 Sustainability Highlights Conference call for investors and analysts 22 Mar... See more »
March 23, 2023FinanzNachrichten
AbbVie: Phase 3 Induction Study With Risankizumab Meets Endpoints
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - AbbVie (ABBV) reported positive top-line results from INSPIRE, a... See more »
March 21, 2023Seeking Alpha
Bayer, Orion's Nubeqa gets approval in China for expanded use in prostate cancer
CEO
Bard is a manufacturer and distributor of vascular, urological, oncological and specialty surgical equipment to the healthcare sector.
Read more